Corticosteroids in ARDS - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Medicine Année : 2023

Corticosteroids in ARDS

Résumé

Acute respiratory distress syndrome (ARDS) is frequently associated with sepsis. ARDS and sepsis exhibit a common pathobiology, namely excessive inflammation. Corticosteroids are powerful anti-inflammatory agents that are routinely used in septic shock and in oxygen-dependent SARS-CoV-2 related acute respiratory failure. Recently, corticosteroids were found to reduce mortality in severe community-acquired pneumonia. Corticosteroids may therefore also have a role to play in the treatment of ARDS. This narrative review was undertaken following a PubMed search for English language reports published before January 2023 using the terms acute respiratory distress syndrome, sepsis and steroids. Additional reports were identified by examining the reference lists of selected articles and based on personnel knowledge of the authors of the field. High-quality research is needed to fully understand the role of corticosteroids in the treatment of ARDS and to determine the optimal timing, dosing and duration of treatment.
Fichier principal
Vignette du fichier
jcm-12-03340.pdf (315.83 Ko) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

hal-04106349 , version 1 (02-06-2023)

Licence

Identifiants

Citer

Emmanuelle Kuperminc, Nicholas Heming, Miguel Carlos, Djillali Annane. Corticosteroids in ARDS. Journal of Clinical Medicine, 2023, 12 (9), ⟨10.3390/jcm12093340⟩. ⟨hal-04106349⟩
40 Consultations
83 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More